✦ LIBER ✦

Peginterferon A-2B 1 MCG/kg dose plus ribavirin 800–1200MG for 24–48 weeks, according to genotype, in naive patients with chronic hepatitis C

✍ Scribed by M. Basso; A. Grasso; G. Percario; E. Azzola; S. Artioli; N. Pelli; S. Blanchi; F. Torre; A. Picciotto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

746 NARLAPREVIR AND PEGINTERFERON ALFA-2

✍ J. de Bruijne; J.F. Bergmann; C.J. Weegink; R. Molenkamp; J. Schinkel; M.A. Trei 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Peginterferon alfa-2b plus weight-based

✍ A. Craxi; S. Koutsounas; P. Ogurtsov; L. Chemello; M. Maticic; J. Torras; M. Dia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

328 Comparison of 48 or 72 weeks of trea

✍ Thomas Berg; M. Von Wagner; H. Hinrichsen; T. Heintges; P. Buggisch; T. Goeser; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

The clinical impact of a 24-week treatme

✍ Maria Grazia Rumi; Roberta D'Ambrosio; Alessio Aghemo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A randomized trial of 24- vs. 48-week co

✍ Ming-Lung Yu; Chia-Yen Dai; Zu-Yau Lin; Li-Po Lee; Nei-Jen Hou; Ming-Yen Hsieh; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

187 Efficacy and safety of 22 weeks of m

✍ Jean-Pierre Bronowicki; Denis Ouzan; Arnaud Tzanck; Tarik Asselah; Herve Desmora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB